描述
Estromon 0.625mg(Conjugated Estrogens)
伊迪蒙 0.625mg （雌三醇雌激素)
在圈内被称作“伊”，有使面部女性化作用的合成雌激素药物
一个月的量：3排 （30粒）
描述
伊迪蒙主要成分是结合雌激素。结合雌激素是多种雌激素的混合物，采用采自天然马尿，以水溶性雌激素硫酸钠盐混合物的形式出现，含有孕马尿液提炼物通常所含的成份。是一种对面部女性化有帮助的药物。
伊迪蒙通常用于治疗绝经后的血管舒缩症状，和其他治疗措施联合使用可以延缓更年期雌激素缺乏引起的骨质酥松症。
被用于跨性别（男变女）激素疗法中：
伊迪蒙在激素疗法中可以起到调节雌激素平衡的作用，正常女性体内同时含有雌酮，雌二醇，此三醇三种雌激素，而倍美力的主要成分中就有多种雌激素，建议配合其他雌二醇药物一起使用可以达到更好的女性化效果。而且根据用户反馈，伊迪蒙对面部女性化的帮助是十分优秀的。伊迪蒙的雌二醇含量较其他雌激素药物相比较低，所以无法单靠其补充每日所需的雌激素水平，一定要配合其他药物一起使用。
伊迪蒙的副作用：
服用伊迪蒙常见的副作用有乳房胀痛，腹泻，头晕恶心，水肿和体重变化。
伊迪蒙的用法用量：
推荐每天在临睡前用温水吞服一颗伊迪蒙，并配合其他激素药物来提升女性化效果。单独服用伊迪蒙是无法补充体内雌激素到所需水平的，所以一定要和其他雌激素药物和抗雄药物一起服用。
伊迪蒙的保存方法：
在低于25°C的阴凉环境中保存。
DESCRIPTION
ESTROMON (Generic of Premarin)
Conjugate Estrogens 0.6 25 mg 1 BOX
Size : 30 Tablets per Box
Are a hormone replacement therapy (HRT) used to manage moderate to severe vasomotor symptoms associated with menopause. Also indicated in atrophic vaginitis, vulvar kraurosis, hypogonadism and female castration and primary chronic failure. Conjugated estrogens used in conjunction with other therapeutic measures (eg diet, calcium, physical therapy) to retard osteoporosis associated with estrogen deficiency in menopausal women.
ACTIVE INGREDIENT: Conjugate Estrogens 0.625mg
DESCRIPTION:
It occurs as a pink round biconvex tablet with a diameter 6.5 mm. engraved “S” script on one side and the other side is smooth
ACTINS AND MODE OR MECHANISMS OF ACTION:Metabolic and Somatic Effects: Estrogens are responsible for the development and maintenance of the female reproductive system and secondary sex characteristics. Estrogens cause growth and development of the vagina, uterus and fallopian tubes, and the enlargement of the breasts. Indirectly, estrogens contribute to the shaping of the skeleton, maintenance of tone and elasticity of urogenital structures, cause changes in the epiphyses of the long bones producing pubertal growth spurt and termination, axillary and pubic hair growth, and pigmentation of the nipples and genitals. In rolonged estrogen deficiency states, the administration of estrogens may alter associated degenerative bone changes. Effect on Menstruation: An ebb and rise of the female gonadal hormone produces the normal menstrual cycle. Indirect effect of
estrogen to induce ovulation is produced by negative feedback at Hypothalamus and Pituitary gland which increases LH levels and induce ovulation. Estrogen levels rise during the first half of the menstrual cycle. At midpoint in the second half of the cycle, the corpus luteum produces high levels of both estrogens and progesterone. Decline of estrogenic activity at the end of the menstrual cycle commonly brings on menstruation, although the cessation of progesterone secretion is the most important factor in this phase of the mature ovulatory cycle. Effects on Nervous System: Estrogens also affect the psychologic and emotional aspects of feminine behavior. As estrogen levels increase during the menstrual cycle, women experience a sense of wellbeing and vigor. In the postmenopausal period, after the decline of endogenous estrogen production, estrogen administration aids in relieving nervous symptoms, such as anxiety, depression and irritability.
INDICATIONS:
Relief of menopausal and postmenopausal symptoms occurring in naturally or surgically induced estrogen deficiency states including vulvar and vaginal atrophy. 2. Prevention and treatment of osteoporosis in naturally occurring or surgically induced estrogendeficiency states. This is in addition to other important therapeutic measures eg. adequate diet and regular exercise. When prescribing solely for the prevention of postmenopausal osteoporosis, therapy should only be considered to be appropriate. 3. Hypoestrogenism due to hypogonadism, castration or primary ovarian failure. 4. Atrophic vaginitis. 5. Vulvar atrophy (with or without pruritis
评价
目前还没有评价